THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Therapeutic Solutions International, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Therapeutic Solutions International, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 5.06B shares, a 46.6% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 5.06B +1.61B +46.6% Sep 30, 2024 10-Q 2024-11-20
Q2 2024 4.66B +1.52B +48.7% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 4.23B +1.48B +53.9% Mar 31, 2024 10-Q 2024-05-30
Q4 2023 3.8B +1.19B +45.3% Dec 31, 2023 10-Q 2024-11-20
Q3 2023 3.45B +863M +33.3% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 3.13B +582M +22.8% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 2.75B +234M +9.3% Mar 31, 2023 10-Q 2023-05-16
Q4 2022 2.62B +306M +13.3% Dec 31, 2022 10-K 2024-04-17
Q3 2022 2.59B +313M +13.8% Sep 30, 2022 10-Q 2022-11-17
Q2 2022 2.55B +293M +13% Jun 30, 2022 10-Q 2022-08-19
Q1 2022 2.51B +271M +12.1% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 2.31B +77.4M +3.46% Dec 31, 2021 10-K 2023-03-29
Q3 2021 2.27B +107M +4.95% Sep 30, 2021 10-Q 2021-11-22
Q2 2021 2.26B +312M +16% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 2.24B +588M +35.5% Mar 31, 2021 10-Q/A 2021-05-21
Q4 2020 2.23B +619M +38.3% Dec 31, 2020 10-K 2022-03-31
Q3 2020 2.17B +729M +50.6% Sep 30, 2020 10-Q 2020-11-17
Q2 2020 1.95B +652M +50.4% Jun 30, 2020 10-Q/A 2020-08-24
Q1 2020 1.66B +555M +50.4% Mar 31, 2020 10-Q/A 2020-07-09
Q4 2019 1.61B +604M +59.7% Dec 31, 2019 10-K/A 2021-04-12
Q3 2019 1.44B +508M +54.5% Sep 30, 2019 10-Q 2019-11-20
Q2 2019 1.3B +404M +45.3% Jun 30, 2019 10-Q 2019-08-16
Q1 2019 1.1B +261M +31% Mar 31, 2019 10-Q 2019-05-20
Q4 2018 1.01B +205M +25.4% Dec 31, 2018 10-K 2020-05-21
Q3 2018 931M +140M +17.6% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 891M +114M +14.7% Jun 30, 2018 10-Q 2018-08-17
Q1 2018 840M +75.1M +9.81% Mar 31, 2018 10-Q/A 2018-05-22
Q4 2017 807M +66.3M +8.95% Dec 31, 2017 10-K 2019-04-15
Q3 2017 792M +96.3M +13.8% Sep 30, 2017 10-Q 2017-11-16
Q2 2017 777M +94.5M +13.8% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 765M +91.5M +13.6% Mar 31, 2017 10-Q 2017-07-05
Q4 2016 740M +199M +36.8% Dec 31, 2016 10-K 2018-04-17
Q3 2016 695M +211M +43.6% Sep 30, 2016 10-Q 2017-04-17
Q2 2016 683M +220M +47.5% Jun 30, 2016 10-Q 2017-04-13
Q1 2016 674M +252M +59.7% Mar 31, 2016 10-Q 2017-03-09
Q4 2015 541M +141M +35.3% Dec 31, 2015 10-K 2017-06-07
Q3 2015 484M +184M +61.3% Sep 30, 2015 10-Q 2016-08-23
Q2 2015 463M +267M +136% Jun 30, 2015 10-Q 2016-07-26
Q1 2015 422M +316M +296% Mar 31, 2015 10-Q 2016-07-06
Q4 2014 400M +306M +323% Dec 31, 2014 10-K 2016-10-31
Q3 2014 300M +211M +235% Sep 30, 2014 10-Q 2016-05-13
Q2 2014 196M +113M +135% Jun 30, 2014 10-Q 2016-05-09
Q1 2014 106M +23M +27.6% Mar 31, 2014 10-Q 2016-04-28
Q4 2013 94.5M -211M -69.1% Dec 31, 2013 10-K 2016-06-16
Q3 2013 89.5M -216M -70.7% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 83.5M -222M -72.7% Jun 30, 2013 10-Q 2013-08-12
Q1 2013 83.5M -222M -72.7% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 305M 0 0% Dec 31, 2012 10-K 2016-04-22
Q3 2012 305M 0 0% Sep 30, 2012 10-Q 2012-11-29
Q2 2012 305M 0 0% Jun 30, 2012 10-Q 2012-11-21
Q1 2012 305M Mar 31, 2012 10-Q 2012-11-19
Q4 2011 305M +277M +964% Dec 31, 2011 10-K 2013-03-29
Q3 2011 305M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 305M Jun 30, 2011 10-Q/A 2011-09-01
Q4 2010 28.7M Dec 31, 2010 10-K 2012-10-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.